PSY Stock Overview
Psych Capital Plc, through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Psych Capital Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.029 |
52 Week High | UK£0 |
52 Week Low | UK£0 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | -3.28% |
1 Year Change | -46.36% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -26.25% |
Recent News & Updates
Recent updates
Shareholder Returns
PSY | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | 0% | -0.4% | 2.2% |
1Y | -46.4% | 62.5% | 3.7% |
Return vs Industry: PSY underperformed the UK Healthcare Services industry which returned 57.9% over the past year.
Return vs Market: PSY underperformed the UK Market which returned 3.8% over the past year.
Price Volatility
PSY volatility | |
---|---|
PSY Average Weekly Movement | 0.6% |
Healthcare Services Industry Average Movement | 5.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PSY has not had significant price volatility in the past 3 months.
Volatility Over Time: PSY's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | Rivki Stern-Youdkevich | https://psych.global |
Psych Capital Plc, through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry. It offers a Software as a Service platform for scientific and regulatory data. The company was incorporated in 2021 and is based in London, the United Kingdom.
Psych Capital Plc Fundamentals Summary
PSY fundamental statistics | |
---|---|
Market cap | UK£8.57m |
Earnings (TTM) | UK£0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs PSY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PSY income statement (TTM) | |
---|---|
Revenue | UK£0 |
Cost of Revenue | UK£0 |
Gross Profit | UK£0 |
Other Expenses | UK£0 |
Earnings | UK£0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did PSY perform over the long term?
See historical performance and comparison